knowledge -WSS

knowledge

author：knowledge 2025-10-02 00:19:18 - browse：4

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Make 'food is medicine' a key part of White House nutrition meeting

leisure time

WSS

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Meta looks to target Twitter with a rival app called Threads

Australia's humpback populations rebound raising hopes of marine scientists

Listen: Biogen's messy board & Laronde's data problem

focus

knowledge

hotspot

New air purifier tech could be key to improving indoor air quality

Did the public have the right to know Arthur Ashe had AIDS?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Option Care buys Amedisys in $3.6 billion home care deal

Medicare details structure of new drug price negotiation program

Van's Gluten Free Original Waffles recalled for possible wheat allergen

Dobbs anniversary: the lost opportunity of abortion as health care

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Jerome Adams on the need for new antivirals for Covid

4th of July breaks record for highest global temperature ever measured

hotspot

Today's health inequities arise from racist U.S. history, say experts

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Connecting traumatic brain injury and domestic violence

Ohio still needs to do more to protect the right to abortion

Ventyx halts psoriasis drug development after lackluster trial results

A letter from the executive editor: STAT UnitedHealth investigation

knowledge

leisure time

hotspot

explore